Bulletin
Investor Alert

G1 Therapeutics Inc.

NAS: GTHX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/203731389/composite

$

13.59

Change

+0.0100 +0.07%

Volume

Volume 11,625

Sep 22, 2020, 5:48 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203731389/composite

Today's close

$ 14.28

$ 13.58

Change

-0.70 -4.90%

Day low

Day high

$13.52

$14.51

Open
Open: 14.40

52 week low

52 week high

$8.80

$35.74

Open

Market cap

$542.85M

Average volume

639,896

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-3.45

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/gthx

MarketWatch News on GTHX

  1. A Big Cancer Conference Could Yield Breakthroughs

    7:10 a.m. Oct. 1, 2019

    - Barron's Online

  2. S&P 500 nails first support, rallies amid bullish sector rotation

    12:00 p.m. Sept. 11, 2019

    - Michael Ashbaugh

  3. G1 Therapeutics upgraded to overweight from neutral at J.P. Morgan

    8:31 a.m. Aug. 8, 2019

    - Tomi Kilgore

  4. G1 Therapeutics downgraded to neutral from overweight at J.P. Morgan

    8:29 a.m. Jan. 23, 2019

    - Tomi Kilgore

  5. G1 Therapeutics started at strong buy with $66 stock price target at Raymond James

    9:30 a.m. Dec. 20, 2018

    - Tomi Kilgore

  6. AstraZeneca Sells $6.6M in G1 Therapeutics Stock

    1:30 p.m. Dec. 5, 2017

    - Barron's Online

  7. Triggering a Debt Bomb

    1:23 a.m. Nov. 11, 2017

    - Barron's Online

  8. G1 Therapeutics started at overweight with $31 stock price target at Wedbush

    8:51 a.m. June 12, 2017

    - Tomi Kilgore

  9. G1 Therapeutics started at overweight with $23 stock price target at J.P. Morgan

    8:44 a.m. June 12, 2017

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/gthx

Other News on GTHX

  1. G1 Therapeutics (GTHX) Investor Presentation - Slideshow

    1:41 p.m. Sept. 18, 2020

    - Seeking Alpha

  2. G1 Therapeutics: Buy, Sell Or Hold

    4:27 p.m. Aug. 30, 2020

    - Seeking Alpha

  3. Oncology Stocks Area Trading Materially Lower The Last 2 Months

    8:00 a.m. Aug. 24, 2020

    - Seeking Alpha

  4. G1 Therapeutics (GTHX) Receives a Buy from Wedbush

    5:09 a.m. Aug. 20, 2020

    - SmarterAnalyst

  5. Needham Issues a Buy Rating on G1 Therapeutics (GTHX)

    7:50 a.m. Aug. 19, 2020

    - SmarterAnalyst

  6. H.C. Wainwright Keeps Their Buy Rating on G1 Therapeutics (GTHX)

    1:55 a.m. Aug. 18, 2020

    - SmarterAnalyst

  7. G1 Therapeutics (GTHX) Investor Presentation - Slideshow

    6:10 p.m. Aug. 13, 2020

    - Seeking Alpha

  8. G1 Therapeutics (GTHX) Gets a Buy Rating from Needham

    11:50 a.m. Aug. 3, 2020

    - SmarterAnalyst

  9. G1 Therapeutics (GTHX) Received its Third Buy in a Row

    6:10 a.m. July 23, 2020

    - SmarterAnalyst

  10. G1 Therapeutics (GTHX) Gets a Buy Rating from Needham

    6:05 a.m. July 23, 2020

    - SmarterAnalyst

  11. G1 Therapeutics inks lerociclib deal with EQRx

    5:52 a.m. July 23, 2020

    - Seeking Alpha

  12. Loading more headlines...
/news/pressrelease/company/us/gthx

Press Releases on GTHX

  1. G1 Therapeutics Announces License Agreement for Lerociclib

    6:00 p.m. July 22, 2020

    - GlobeNewswire

  2. G1 Therapeutics Announces License Agreement for Lerociclib

    6:00 p.m. July 22, 2020

    - GlobeNewswire

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.